Transaction · 0001193125-26-355561

POST LEONARD E

POST LEONARD E, DIR, reported a transaction classified as exercise at CG Oncology, Inc. involving 1000.000000 shares for an estimated $600.00. Reported holdings after the transaction were 1000.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MDIR
CGONCG Oncology, Inc.
Filing timeAug 18
Trade dateAug 14, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$76.29
Pre-filing
1mo ago -4.3%1w ago -1.6%1d ago -2.1%
Returns since
7d +3.2%30d -0.6%90d -0.6%180d -0.6%1y -0.6%

CGON price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CGON since 2026-08-18Filed 17 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001193125-26-355561
Common Stock
Transaction date
Aug 14, 2026
Filed Aug 18, 2026, 08:30 PM · 4d delay
Shares
1.00k sh
$60 per share
Estimated value
$60.0k
Computed from shares × price
Holdings after
1.00k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.

  2. F2

    Fully vested

Original filing · 0001193125-26-355561
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CGON